sonofnels
12 months ago
To all shareholders of Altavoz Entertainment Inc.,
We, the concerned shareholders of Altavoz Entertainment Inc., are writing to express our deep concern about the current state of affairs within our company. We believe that the current slate of officers has failed to fulfill their duties and responsibilities to the shareholders of the company.
As shareholders, we believe that we have a right to be represented by a competent and accountable leadership team. We are therefore requesting that the current slate of officers step down and that we, the shareholders, be given the opportunity to elect our own slate of officers to lead the company.
We believe that this is necessary in order to restore investor confidence in the company and to ensure that our investments are being properly managed. We urge all shareholders to support this effort and to exercise their right to vote for a new slate of officers.
Thank you for your attention to this matter.
Sincerely,
Nelson R Jacobsen, shareholder former ceo
May 3rd 2023
sonofnels
1 year ago
Asked ChatGTP to summarize :
Based on the provided shareholder update, there are several concerns that a common shareholder of Altavoz Entertainment Inc. may be worried about. Here are five bullet points summarizing those concerns:
Legal issues and leadership changes: Altavoz Entertainment Inc. and its subsidiary Nurish.Me LLC faced garnishments on their bank account and lawsuits, which consumed free cash and required payments for lawyers and settlements. In addition, the company experienced significant changes in leadership in 2022, including resignations of the subsidiary's CEO and Chief Formulation Officer, as well as board members.
Special shareholder meeting and accusations: A shareholder with an interest greater than 10% requested a special shareholder meeting, where a motion was put forward to elect David Perez to the board but failed to get enough votes. During the meeting, David Perez accused two other directors of wrongdoing, which led to an internal investigation that found no evidence of any wrongdoing by them. The investigation, however, revealed that Perez gave away more than one million dollars of retail value of products without any revenue opportunities.
Misleading actions by David Perez: David Perez misrepresented himself as being linked to the company after his official address was removed from him when he stepped down as Chairman and CEO in September 2021. He also set up a domain separate from the company's official website and used an email address to represent himself, causing confusion among several parties. Moreover, he accessed company assets without any written or verbal management approval, resulting in an outstanding account with Nurish.me LLC.
Limited access to cash and poor performance: Altavoz Entertainment Inc. faced limited access to cash, and its engagement with InSocial, a social media company, delivered less than optimum outcomes for Nurish.me. As a result, the InSocial contract was terminated, and a subsequent opportunity to merge with another company in December 2022 did not materialize.
Product issues and concerns raised in reverse merger: The company faced challenges with some of its products expiring this month, and new liquid CoreCumin production would only commence in early March. In addition, the company is investigating concerns raised by persons involved in the reverse merger between Altavoz Entertainment Inc. and Nurish.me LLC in relation to the finalization of the merger deal.
Overall, the update suggests that the company is facing several challenges, including legal issues, leadership changes, poor performance, limited access to cash, and product issues. Common shareholders may be worried about these concerns and the company's ability to overcome them.
sonofnels
1 year ago
Altavoz Entertainment Inc. Shareholder Update
14th February 2023
We are pleased to release our financial figures for 2022 on OTC markets under ticker code AVOZ.
2022 was a challenging year for Altavoz Entertainment Inc and its subsidiary Nurish.Me LLC. In the first half of the year, our growth plans were impacted by garnishments on our bank account and lawsuits with Bioscience Xtra Ltd and Venture Investment Group, which we had to navigate. As a result, our free cash was consumed by paying for lawyers and managing the settlements of actions against Nurish.me and our own counterclaim. Additionally, we incurred two years of accounting services in 2022, namely the financials for 2020 and 2021. Furthermore, GAAP Genies provided accounting services up to June 2022 before being re-engaged to complete the 2022 accounts in preparation for a merger opportunity. Altavoz Entertainment Inc now meets the requirements to uplift to Pink Current status based on the work performed by GAAP Genies over the past 18 months. This is a significant milestone that has been achieved
We experienced some significant changes in our leadership in 2022. We received resignations from subsidiary Nurish.me LLC, CEO and Chief Formulation Officer on June 23, 2022, following the Venture Investment Group $7.8 million judgement. Moreover, we informed shareholders that members of the board had resigned. However, a recent review of notices found that they had resigned specifically from the subsidiary Nurish.me LLC and not their positions as directors of the Altavoz Entertainment Inc board.
Isaac Management, a shareholder with an interest greater than 10%, requested a special shareholder meeting be called, which was held on August 24, 2022, at 1 pm ET. During the meeting, a motion was put forward to elect David Perez to the board, but it failed to get more than 50% of the eligible vote and was dismissed. We also discussed the financial position of the company and presented a plan moving forward to shareholders in attendance, along with an audio statement from the former CEO Caesar Kavadoy.
David Perez towards the end of the Special Shareholder Meeting accused both Dr Michal Heger and Dr John Lewis of wrongdoing. An internal investigation found that Morris Formulations owned by Dr Lewis had no agreement in place with Nurish.me to sell his product and therefore was free to sell their product elsewhere. Dr Hegers employment agreement also gave provision for liquid CoreCumin sales in markets outside of North America therefore was able to do so and was entitled to $2m in revenue, with a 25% share being returned to Nurish.me when that number was reached. Sales in the liquid Corecumin are not material in nature to date. Furthermore investigations found David Perez during his tenure as CEO of Nurish.me Inc/Altavoz Entertainment Inc gave away in excess of one million dollars retail value of products with no apparent revenue opportunities derived from these massive handouts of free product.
Following the Special Shareholder Meeting David Perez managed to persuade Nurish.me LLC distribution and warehousing partner, WSA Distribution to release in excess of $50K of retail product to him making representation that he was entitled to this and had permission to access company assets without any written or verbal management approval. WSA at the time was under clear instruction not to release any product to David Perez without prior written management approval, this was clearly fraudulent misrepresentation on Davids behalf and WSA acted on that misrepresentation. San Diego Police Dept were engaged however a decision not to press criminal charges on David as a founding partner and a major shareholder was made, instead we made an offer for him to purchase these company assets at cost rather than face criminal charges. His account with Nurish.me LLC remains outstanding today.
David Perez also sort to mislead investors, customers and the public by setting up a domain separate from the companies official www.nurish.me and set up www.nurishme.com
and using the email address david@nurishme.com to represent himself being linked to the company after his official address david@nurish.me was removed from him when he stood down as Chairman and CEO in September 2021. The actions have caused confusion amongst several parties.
Following the Special Shareholder meeting, we attempted to discuss pathways forward with noteholders, but some parties either failed to enter discussions or dismissed the attempts to renegotiate their notes to salvage the company. The major judgment holder, Venture Investments Group, remained willing to negotiate a position that everyone could benefit from.
We began a search for a replacement CEO; however, with limited access to cash and several less-than-suitable candidates, we had to draw this exercise to a close.
InSocial, our social media company, who were brought in by a former CEO, continued to deliver less than optimum outcomes for Nurish.me. Our engagement with Disruptify was put in place access the former Nurish.me employee Kevin Huff to drive sales and oversee the InSocial contract. However, after another period of poor performance between September and November 2022, the InSocial contract was terminated. Disruptify proposed delivering what the InSocial team had been delivering, but at a lower cost. There has been transparency that Caesar Kavadoy was a director of both companies Disruptify and Altavoz Entertainment Inc as he disclosed his interested when he had Disruptify produce his CEO video updates previously and Nurish.me LLC incurred fees for these services.
We identified an opportunity to merge with a company in December that had more than $20 million in revenue and was looking to triple that in six months. Unfortunately, the noteholders of Altavoz Entertainment Inc showed limited interest, with only two parties willing to look at a proposal.
A subsequent opportunity arose in January 2023 with another party for a potential merger however noteholders showed no interest in renegotiating their position or entertaining a conversation. With no flexibility to negotiate a path forward which would involve fresh capital the ability for Nurish.me to trade out of its current position seems unlikely.
In December, we finalized a distribution agreement through Disruptify to access Dr. John Lewis CogniNurish product for resale through Nurish.me. This deal was put in place by former CEO Caesar Kavadoy to ensure that if the Altavoz Entertainment Inc or Nurish.me LLC business saw a former CEO and Chairman return to the company, supply would cease immediately.
Following the shareholder meeting on August 24, 2022, the company paid royalties to Dr. Lewis in good faith until the distribution agreement was signed. However, we regret to inform you that Dr. Lewis terminated his relationship with Disruptify on January 29, 2023, leaving us without the CogniNurish product.
Despite our attempts to see Disruptify restore their relationship with Dr John Lewis, they failed to achieve this. While Disruptify have offered to supply us with an alternative product, we will attempt to negotiate directly with Morris Formulations to resume selling their proven product line at Nurish.me. However, we cannot guarantee this, as there are outstanding unpaid costs from more than three years ago, and past issues between the two entities need to be resolved.
Moreover, we are facing some challenges such as some of our products may be expiring this month and new liquid CoreCumin production will only commence in early March. We have been working closely with 10X Health Systems to supply both CogniNurish and Liquid CoreCumin in bulk. However, some production facility issues, and tight cash flow are currently restricting our ability to commercialize this opportunity.
We are also investigating concerns raised by persons involved in the reverse merger between Altavoz Entertainment Inc. and Nurish.me LLC (Florida) in relation to finalization of the merger deal. We expect to provide an update in the coming weeks.
We want to be transparent with you and inform you that it is likely the board will call a shareholder meeting in the coming weeks to present some options for Altavoz Entertainment Inc. moving forward.
We will keep you updated on any further developments.
Altavoz Entertainment Inc.
This release includes additional documents.
Click on the link(s) below to view.
Altavoz Entertainment Inc - Shareholder Update 14 February 2023.pdf
AskMuncher
2 years ago
$AVOZ Nurish.Me Quarter 4, 2021 CEO Update - Video Transcript
Press Release | 02/01/2022
February 1, 2022
OTC Disclosure & News Service
La Jolla, CA —
This release includes additional documents. Select the link(s) below to view.
NurishMe Q4 2021 CEO Transcript.pdf
Nurish.Me (Altavoz Entertainment Inc) CEO Caesar Kavadoy shares his first video update to the companies shareholders, noteholders, customers, business partners, affiliates and influencers.
Moving forward our intention is to provide quarterly video CEO updates that will be posted here and on our website. To view, the CEO Update Video click here A transcript of the video is also attached.
Forward-Looking Statements
Forward-looking statements involve risks and uncertainties. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology including "could," "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential," and the negative of these terms or other comparable terminology. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions, or other future performance suggested in this report. Except as required by applicable law, we do not intend to update any of the forward-looking statements so as to conform these statements to actual results. Investors should refer to the risks disclosed in the Company's reports filed from time to time with the Securities and Exchange Commission and available at www.sec.gov.
sonofnels
3 years ago
Since Im getting an MBA figured I would put it to use and offer some ratio's on what is posted.
https://www.otcmarkets.com/otcapi/company/financial-report/304505/content
Debt to Asset Ratio 2,470,802 /606,664 = 4
Debt to Equity 2470802/(1,864,138) = -1.325
Current Ratio 354,195/2,159,402 =0.16
Quick Ratio 2,204-285,956/ 2,159,402 =-.0131
Numbers are what they are.....
sonofnels
3 years ago
I was the CEO that took over the dormant MXMI and reversed by the company into it, changed the name, sysm, and keep it current until a group of shareholders got together with our lawyer and said, despite it being a full BUCK said I wasn't running well enough and they had a better company.
So Altavoz was reversed out and whatever this new company is pretending to be.
MGMT or Lawyer is not talking to anyone, or resonding to request for info via NV disclosure laws, they're not paying bills since we still get them, despite not being the operating company.
They are complete failures and anyone that pumped them here needs to explain to shareholders how they knew info that no one else did let alone regulators?
So we are all getting Fuked and SEC is going to close this company down, as Im getting notices about this from lawyers asking what I;m going to do. I tell them and one has come back with interested parties about buying the husk of this public co.
If you want to be part of the solution please reach out to me nelson @ altavoz.com
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
molee
3 months ago
MattyTrader
11 months ago
capri28
2 years ago
Longer Than Most
2 years ago
Hot Features
Premium
